Other Viruses Citation List: February 14 - February 27, 2014
Hepatitis C Virus
1. Multiple e-Pharmacophore Modeling, 3D-QSAR, and High-throughput Virtual Screening of Hepatitis C Virus NS5B Polymerase Inhibitors. Therese, P.J., D. Manvar, S. Kondepudi, M.B. Battu, D. Sriram, A. Basu, P. Yogeeswari, and N. Kaushik-Basu. Journal of Chemical Information and Modeling, 2014. 54(2): p. 539-552; PMID[24460140].
[PubMed]. OV_0214-022714.
2. Dual Inhibition of HCV and HIV by Ring-Expanded Nucleosides Containing the 5:7-Fused imidazo[4,5-e][1,3]diazepine Ring System. In Vitro Results and Implications. Zhang, N., P. Zhang, A. Baier, L. Cova, and R.S. Hosmane. Bioorganic & Medicinal Chemistry Letters, 2014. 24(4): p. 1154-1157; PMID[24461293].
[PubMed]. OV_0214-022714.
Citations from the ISI Web of Knowledge Listings for O.V.
3. Structure-guided Design Affirms Inhibitors of Hepatitis C Virus P7 as a Viable Class of Antivirals Targeting Virion Release. Foster, T.L., G.S. Thompson, A.P. Kalverda, J. Kankanala, M. Bentham, L.F. Wetherill, J. Thompson, A.M. Barker, D. Clarke, M. Noerenberg, A.R. Pearson, D.J. Rowlands, S.W. Homans, M. Harris, R. Foster, and S. Griffin. Hepatology, 2014. 59(2): p. 408-422; ISI[000330310300009].
[WOS]. OV_0214-022714.
4. Ipilimumab-induced Hepatitis C Viral Suppression. Minter, S., I. Willner, and K. Shirai. Journal of Clinical Oncology, 2013. 31(19): p. E307-E308; ISI[000330520600003].
[WOS]. OV_0214-022714.
5. The Rigid Amphipathic Fusion Inhibitor dUY11 Acts through Photosensitization of Viruses. Vigant, F., A. Hollmann, J. Lee, N.C. Santos, M.E. Jung, and B. Lee. Journal of Virology, 2014. 88(3): p. 1849-1853; ISI[000329857000044].
[WOS]. OV_0214-022714.